TOPAS Advanced Polymers
Americas: +1 248 479 8928  Asia: +81 03 6711 8610
Europe, ME, Africa: +49 1805-1-86727


Polyplastics Develops New “DURACON® POM PM Series” for Medical/Healthcare Industry

The Polyplastics Group has announced the development of the DURACON® polyoxymethylene (POM) PM series for drug contact and delivery applications in the medical/healthcare market. The new PM series complements Polyplastics’ TOPAS® cyclic olefin copolymer (COC), a high-purity medical plastic for a range of healthcare applications.

The first grade under the PM series, DURACON POM PM09S01N, delivers global medical and food regulatory compliance. In a changing and growing marketplace, medical device manufacturers and end users demand high-quality materials and reliable suppliers, according to Polyplastics, which is a global manufacturer of POM materials for diverse end-use markets.

The new POM grade meets regulatory compliance requirements, including ISO 10993 and USP Class VI biocompatibility/cytotoxicity, FDA Drug Master File (DMF) and Device Master File (MAF), and EU 10/2011 and FDA food contact 21 CFR 177.2470.

The material also adheres to strict quality management systems, including conformity to the VDI 2017 medical-grade plastics standard. It also provides full traceability of processes and products, and production management based on the GMP principle. Polyplastics also provides uniform quality and global supply.

Polyplastics offers medical device manufacturers extensive data on the long-term reliability of its materials. Customized data on extraction, moldability, durability, slip and wear, and other key attributes are also available.

TOPAS COC is a glass-clear and highly pure medical polymer which offers stiffness and barrier, biocompatibility, and drug compatibility for wearables, drug delivery, medical devices, pharmaceutical blisters and trays, and diagnostics and microfluidics.

Polyplastics will highlight the PM series and TOPAS COC at the Pharmapack exhibition in Paris, France (Booth #B92), February 6-7, 2019, and MD&M West in Anaheim, Calif., U.S. (Booth #666), February 5-7, 2019.

For more detailed product information, please visit:

Press Contact: 
Miyuki Hedenstrom Hanaka
+81 3 6711 8610

miyuki.hanaka [at]

About TOPAS Advanced Polymers and Polyplastics

TOPAS Advanced Polymers is the world’s leading maker of COC (cyclic olefin copolymer), a glass-clear and extremely pure plastic for healthcare, optics, packaging, and electronics applications. From insulin delivery, to food contact films, to tablet and smartphone components, TOPAS® COC is the high performance material of choice. The broad global regulatory compliance of TOPAS COC can make your next development a simpler task. 

TOPAS Advanced Polymers is a business of Polyplastics Co., Ltd., a global leader in the development and production of engineering thermoplastic solutions. Along with COC, the company’s broad product portfolio includes POM, PPS, PBT, and LCP plastics. The company has the largest global market share of POM, LCP and COC. With more than 50 years of experience, the company is backed by a strong global network of R&D, production, and sales resources capable of creating advanced solutions for an ever-changing global marketplace.

TOPAS® is a registered trademark of TOPAS Advanced Polymers GmbH in Germany, the United States, and other countries for its family of cyclic olefin copolymer resins.